Skip to main content

IME Supplement, November/December 2026, Modern Refractive Surgery

Page 1

IME SUPPLEMENT | NOVEMBER/DECEMBER 2026

M

MODERN REFRACTIVE SURGERY—

Bridging Technology, Outcomes, and Patient Expectations Education

FORUM


ESCRS Clinical Trends in Refractive Surgery BY ANDREIA ROSA, MD, PhD

F

or the 11th consecutive year, the ESCRS Clinical Trends Survey has tracked evolving clinical practice in cataract and refractive surgery, while highlighting areas of unmet need. The 2025 survey, conducted online and onsite during the 43rd Congress of the ESCRS in Copenhagen, comprised 120 questions and received responses from more than 2,300 delegates. The survey offers a valuable overview of technology adoption, surgical practice, and the factors influencing refractive surgery. Key findings are being presented in a series of topic-specific EuroTimes Reports developed in collaboration with ESCRS expert leaders. Building on this work, the 2026 Clinical Trends Survey was launched at the 44th Congress of the ESCRS in London, continuing the programme’s monitoring of clinical practice and supporting evidence-based decision-making.

Current Practice and Barriers

Approximately half of respondents reported performing refractive surgery, with a mean annual volume of approximately 230 procedures per surgeon. Among surgeons performing intrastromal lenticule extraction procedures, the mean annual volume was approximately 66 procedures per surgeon. Among those implanting phakic intraocular lens (IOLs), the corresponding figure was approximatelty 32 implantations per surgeon. Phakic IOLs implantation remains relatively uncommon among the wider survey population, with 64% of respondents reporting that they do not implant phakic IOLs. Cost was the leading barrier to performing additional refractive procedures, cited by 71% of respondents. Concerns about surgical outcomes or complications were reported by 18%, while lack of training or confidence and limited access to equipment were each cited by 13%. The survey also highlighted an educational gap, with nearly half of respondents selecting categories such as very inadequate, somewhat inadequate and adequate, when rating their knowledge of refractive surgery technologies (Figure 1).

“Nearly half of the surgeons rated their knowledge of refractive surgery as adequate or below, highlighting an important educational need.”

Ablation Profiles

Standard/wavefront-optimized ablation profiles remained the most frequently reported approach, accounting for 47%. Wavefront-customized procedures accounted for 19%, topography-customized procedures for 16%, and intrastromal lenticule extraction for 12%. The findings show that established ablation profiles remain widely used, while customized approaches represent a substantial component of contemporary refractive practice. This diversity of treatment strategies reflects the broader evolution of refractive surgery towards increasingly individualized treatment planning.

Conclusion

The 2025 ESCRS Clinical Trends Survey highlights a refractive surgery landscape in transition. Technology continues to expand treatment options, but adoption is influenced by cost, surgeon confidence, training, and concerns about outcomes. At the same time, the continued use of both established and customized treatment profiles underscores the importance of matching technology to individual patient needs. Ultimately, modern refractive surgery is not defined by technology alone. Success depends on selecting the right technology for the right patient, supported by appropriate training, evidence-based decision-making, and realistic expectations.

ESCRS Clinical Trends Survey: How would you rate your knowledge of refractive surgery technologies? Dr. Andreia Rosa is a cornea and refractive surgeon and keratoconus specialist at Hospital da Luz Coimbra, ULS Coimbra, and Martins Rosa Serviços de Saúde. She is also a Professor at the Faculty of Medicine, University of Coimbra, an elected member of the ESCRS Council, a member of the ESCRS Programme Committee, and chair of the ESONT Committee. Dr. Rosa can be contacted at andreia.rosa@gmail.com.

32% 27% 22% 15%

4% Very good

Good

Adequate

Somewhat inadequate

Very inadequate

FIGURE 1. 46% of ESCRS Clinical Trends Survey respondents rated their knowledge of refractive surgery technologies as average or inadequate.

2

Financial Disclosures: Consultant for Alcon, Davi, and EDOL.

EuroTimes Supplement November/December 2026 | Modern Refractive Surgery–Bridging Technology, Outcomes, and Patient Expectations


Preoperative Precision: The Foundation for Success in Refractive Surgery BY TIAGO MONTEIRO, MD, PhD, FEBO, FEBOS-CR

T

he success of refractive surgery over the last three decades can be broadly considered in two key areas: efficacy and safety. Efficacy has benefited from increasingly accurate refraction, eye tracking, cyclotorsion control, and evolving ablation profiles. Surface ablation has also advanced through improved management of corneal scarring and epithelial healing, as well as greater treatment customization. Safety has evolved alongside these advances, with the introduction of femtosecond laser technology, increasingly sophisticated preoperative screening, biomechanical assessment, and mitomycin C in surface ablation. Together, these developments have made refractive surgery increasingly precise, predictable, and safe.

Efficacy: Precision in Measurement and Treatment Refraction: The Foundation of Precision

Refraction may sometimes be overlooked, but it remains a core component of the refractive surgery examination. A comprehensive assessment should include subjective refraction, spherical and cylindrical refraction, cycloplegic refraction when indicated, ocular dominance, and pupillometry. It is particularly important to correlate refractive astigmatism with topographic astigmatism. Cycloplegic refraction is important when accommodation may influence measurements or when subjective and objective findings differ. Pupillometry can also help anticipate visual symptoms under mesopic and scotopic conditions, including potential nightvision disturbances.

Epithelial Mapping: From Diagnosis to Treatment

Epithelial mapping has become a valuable component of preoperative assessment, particularly for identifying corneal warpage in contact lens

wearers1. Before the cornea has stabilized after contact lens wear, refraction, particularly the astigmatic component, may not accurately reflect the patient’s true refractive status.

“Use epithelial mapping to identify corneal warpage, and do not rely on a refraction obtained before adequate contact lens discontinuation.” Epithelial mapping has also become increasingly relevant in surface ablation. In Southern Europe, we see a significant number of patients with naturally thin corneas, for whom photorefractive keratectomy (PRK) remains an important surgical option. Epithelial mapping can support transepithelial PRK and treatment customization, with the potential to facilitate epithelial healing and reduce postoperative discomfort. Beyond refractive surgery, it may also have therapeutic applications in selected corneal conditions. Epithelial mapping has, therefore, evolved from a primarily diagnostic tool into an important component of patient selection, treatment customization, and therapeutic corneal management.

Advances in Treatment Precision

At the other end of the spectrum, we now have technologies capable of performing ray-tracing refraction2. These systems incorporate multiple optical parameters, including the anterior and posterior corneal surfaces, corneal thickness, lens position, and axial length, to create a personalized representation of the patient’s optical system and, potentially, a customized ablation profile. This represents an evolution toward increasingly objective and individualized optical measurements. It may contribute to greater precision in refractive surgery and, in selected cases, enable highly customized ablation profiles. The introduction of cyclotorsion control has been another major advance in the treatment of astigmatism. By identifying and compensating for cyclotorsional movement, we can more accurately align the treatment with the patient’s astigmatic axis, improving the predictability of astigmatic correction and contributing to excellent uncorrected visual acuity.

Safety: Precision in Patient Selection

Safety begins with preventing complications and accurately identifying patients who are not suitable candidates for corneal laser vision correction (LVC). Preoperative assessment should include careful evaluation of corneal structure and biomechanical stability using corneal tomography and, when appropriate, biomechanical assessment (Figure 1). The potential biomechanical impact of LVC should also be considered, including corneal thickness, flap thickness and geometry, and ablation depth. Particular attention should be paid to identifying corneal abnormalities, forme fruste keratoconus, and other features associated with an increased risk of ectasia, while also accurately characterizing corneal astigmatism.

Modern Refractive Surgery–Bridging Technology, Outcomes, and Patient Expectations | EuroTimes Supplement November/December 2026

3


Parameter

Data to collect

Pachymetry

Corneal thickness (RSB), PTA (%)

Corneal Topography Corneal Tomography

Exclude corneal pathology, assessment of corneal astigmatism > 1.500 cells/mm2

Specular microscopy

Biometry

Exclude Fuchs dystrophy or Posterior Polymorphic dystrophy – risk of corneal decompensation and loss of refractive predictability, loss lines CDVA, myopic regression Axial Length Progression / treatment regression Quality of vision Corneal scar and transparency – depth, density

AS-OCT

Topography guided ablation in pathologic cornea Refractive enhancements – surface ablation or flap-lift Associated procedures – previous keratoplasty, lensectomy or phakic IOL

Corneal Biomechanics OCT

Tonometer*: ARTh, CBI, TBI Macular and optic disc

* Corvis ST Figure 1. Ancillary tests for preoperative evaluation. Courtesy of Dr. Tiago Monteiro.

Parameter

Instruments

Cut-off values

BAD-D (Belin-Ambrosio display deviation)

Scheimpflug*

D < 1.2 ART max > 400

TBI (Tomographic & Biomechanical Index)

Scheimpflug* Tonometer**

< 0.16

ERSS (Ectasia Risk Score System)

Topography

High Risk > 4 points Moderate Risk 3 points Low Risk <= 2 points

PTA (Percentage of Tissue Altered)

None

PRK and LASIK < 34% mPTA ReLEx < 20%

Clinical and medical history

Age Family history Allergies Medication Profession

Clinical factors

* Pentacam, ** Corvis ST Figure 2. Cut-off values used in the assessment of corneal ectasia risk in laser vision correction. Courtesy of Dr. Tiago Monteiro.

Several diagnostic tools can support this assessment (Figure 2). Commonly used measures include the Belin-Ambrósio deviation (BAD-D) and Tomographic and Biomechanical Index (TBI), while the Ectasia Risk Score System (ERSS) and Percentage of Tissue Altered (PTA) can provide additional information when evaluating suitability for LVC. However, no individual parameter should be considered in isolation. Clinical judgment and the patient’s history remain essential. Age, family history, allergies, previous ocular surgery, medications, and occupational or lifestyle factors may all contribute to the overall assessment of suitability and risk.

“Precision also means selecting the right procedure for the right patient.”

Choosing the Right Procedure

The choice among surface ablation, LASIK, and lenticule extraction should be guided by corneal characteristics, refractive error, lifestyle, occupational demands, expected recovery, and patient cooperation.

4

Surface ablation may be considered for corneal scarring, high risk of ocular trauma, epithelial basement membrane dystrophy, recurrent corneal erosion, lower corrections (SE < -4.0 D), and selected younger or less cooperative patients. LASIK may be preferred when rapid visual recovery and minimal postoperative discomfort are priorities and may be appropriate for hyperopia or larger corrections (SE -4.0 to -8.0 D), with or without significant astigmatism. Finally, precision means anticipating and minimizing postoperative complications. Dry eye symptoms are among the most common postoperative complaints following laser vision correction, making careful preoperative assessment essential.3,4 Risk factors include an abnormal preoperative Schirmer test, female sex, Asian ethnicity, greater ablation depth, long-term contact lens wear, and the use of mechanical microkeratomes. Identifying these factors during the preoperative evaluation allows the ocular surface to be optimized before surgery and can help guide the choice of procedure. In patients at increased risk of postoperative dry eye, surface ablation or phakic IOL implantation may be considered as alternatives to flap-based procedures, depending on the individual clinical profile.

Conclusion

Precision is central to achieving predictable outcomes after refractive surgery. It involves integrating refraction with topography, tomography, and epithelial mapping, incorporating emerging ray-tracing approaches, and tailoring the procedure to the individual patient. It also requires careful assessment of corneal biomechanics, individualized surgical planning, and proactive strategies to minimize complications such as corneal ectasia and dry eye. Ultimately, precision means the right assessment, the right procedure, and the right patient. REFERENCES: 1. Schallhorn JM, Tang M, Li Y, Louie DJ, Chamberlain W, Huang D. Distinguishing between contact lens warpage and ectasia: Usefulness of optical coherence tomography epithelial thickness mapping. J Cataract Refract Surg. 2017;43(1):60-66. 2. Kanellopoulos AJ. Initial Outcomes with Customized Myopic LASIK, Guided by Au-

EuroTimes Supplement November/December 2026 | Modern Refractive Surgery–Bridging Technology, Outcomes, and Patient Expectations


tomated Ray Tracing Optimization: A Novel Technique. Clin Ophthalmol. 2020;14:39553963. 3. Kobashi H, Kamiya K, Shimizu K. Dry Eye After Small Incision Lenticule Extraction and Femtosecond Laser-Assisted LASIK: Meta-Analysis. Cornea. 2017;36(1):85-91. 4. Sambhi RDS, Sambhi GDS, Mather R, Malvankar-Mehta MS. Dry eye after refractive surgery: a meta-analysis. Can J Ophthalmol. 2020;55(2):99-106.

Dr. Tiago Monteiro is a specialist in anterior segment pathology, including cornea, cataract and refractive surgery at ULS São João, Porto, and Instituto CUF, Porto. Dr. Monteiro can be contacted at monteiro.tiago.pt@gmail.com.

Financial Disclosures: Speaker bureau for Alcon, WaveLight, STAAR Surgical, Johnson & Jonhson, and Théa Laboratories.

The Impact of Ocular Surface Disease in Refractive Surgery BY BÉATRICE COCHENER-LAMARD, MD, PhD, FEBO

T

he ocular surface forms the eye’s first refracting interface, comprising the corneal epithelium and tear film. Even subtle irregularities can affect topography, keratometry, and aberrometry, compromising refractive accuracy, visual outcomes, and patient satisfaction. The 2025 ESCRS Clinical Trends Survey highlights this impact: 79% of cataract surgeons reported that mild-to-moderate dry eye significantly or very significantly affects keratometry and IOL power calculations, while 63% would likely or very likely postpone surgery in patients with moderate dry eye until it was better managed.

Dry Eye: A Common Pre-Existing or Procedure-Induced Condition

Meibomian gland dysfunction (MGD) and Demodex blepharitis are important ocular surface conditions to address before refractive and cataract surgery. Dry eye may be present before surgery or develop or worsen postoperatively. Survey respondents reported seeing approximately 50 patients with dry eye monthly and estimated the postoperative prevalence to be 17% after laser vision correction and 6% after intrastromal lenticule extraction. Symptoms include fluctuating vision, higher-order aberrations, inaccurate preoperative measurements, postoperative discomfort, and glare. These issues can reduce patient satisfaction, even when uncorrected visual acuity reaches 20/20.

“Once a patient is dissatisfied with their visual outcome, it can be difficult to explain that the underlying problem was already present before surgery.”

Demodex Blepharitis: Recognizing the Clinical Signs

Of the approximately 100 Demodex species found on humans, two are particularly relevant to ocular health: Demodex folliculorum, which inhabits eyelash follicles, and Demodex brevis, which burrows into sebaceous and meibomian glands.1 Demodex prevalence increases with age, and colonization is particularly common in older adults. Overgrowth can cause Demodex blepharitis, characterized by collarettes– cylindrical deposits around the base of the eyelashes and the hallmark clinical sign of the condition2–as well as eyelid redness, inflammation, and irritation. The condition may also coexist with MGD and rosacea.

“Look for one key clinical sign: collarettes – the pathognomonic sign of Demodex blepharitis.”

MGD: A Key Cause of Evaporative Dry Eye

MGD is a leading cause of evaporative dry eye. Its prevalence increases with age and may be exacerbated by prolonged screen use. Often underdiagnosed, MGD compromises tear film stability, affecting preoperative measurements, treatment planning, and postoperative outcomes. Symptoms include a foreign-body sensation, fluctuating or blurred vision, and ocular discomfort.

Comprehensive Preoperative Ocular Surface Assessment

A comprehensive preoperative assessment is essential (Figure 1). Even a

Modern Refractive Surgery–Bridging Technology, Outcomes, and Patient Expectations | EuroTimes Supplement November/December 2026

5


▪ Comprehensive Eye Exam • Visual acuity • Refraction • Slit-lamp, MGE • Pupil size • Fundus • IOP • Life questionnaire (Speed, DEQ, OSDI ...)

▪ Corneal Analysis • Topography • Pachymetry • Corneal sensitivity

▪ Overall Eye Health Evaluation • Medical history • Ocular surface • Retinal health

▪ Biomarking • Schirmer: controversial • Lissamine green: for clinical trial • Osmolarity • Inflammation marker: MMP-9

▪ Imaging • NI BUT • Aberrometry (OSI, Tracey...) • AS OCT: Epithelial mapping • Meibography • Confocal microscopy (postop)

Figure 1. Diagnostic workup, including basic and specialized assessment tools. Courtesy of Prof. Béatrice Cochener-Lamard.

properly performed fluorescein examination provides valuable information about tear film stability and epithelial integrity. When ocular surface disease (OSD) is suspected, questionnaires help assess symptoms and their impact on daily life. Medication use, age-related changes, and lifestyle factors should also be considered. Additional diagnostic tools include non-invasive tear breakup time, aberrometry, epithelial mapping, and meibography. Although the role of the Schirmer test remains debated, it may provide complementary information. In vivo confocal microscopy can be useful in selected cases, but it is not routinely required. Combining clinical findings, patient-reported symptoms, and targeted testing helps identify abnormalities before they compromise refractive accuracy or surgical outcomes.

Key Considerations for Optimal Surgical Outcomes

Before surgery, identify risk factors such as allergies, eye rubbing, occupational and sporting activities, and contact lens wear. Assess tear film stability, keratitis, and MGD at the slit lamp. Repeat corneal imaging when measurements fluctuate, treat OSD, and reassess stability. Postpone surgery, when necessary, consider surface ablation in selected patients, and counsel patients about realistic expectations. During surgery, minimize ocular surface stress by limiting topical anesthetic use, carefully positioning the speculum or suction ring, reducing microscope light exposure, and maintaining adequate ocular surface lubrication. After surgery, monitor patients closely, reinforce lubrication, and arrange long-term follow-up for persistent OSD. Tailor treatment to severity, ranging from artificial tears to anti-inflammatory or systemic therapies when indicated.

6

EuroTimes Supplement November/December 2026 | Modern Refractive Surgery–Bridging Technology, Outcomes, and Patient Expectations


Figure 2. Preoperative ocular surface optimization. Courtesy of Prof. Béatrice Cochener-Lamard.

Preoperative optimization may include targeted MGD treatment, tear film restoration, and inflammation modulation (Figure 2).

New Option: Crosslinked Hyaluronate Canalicular Filler

A crosslinked hyaluronate canalicular filler is a gel-like device that reduces tear drainage by filling the canalicular lumen and blocking tear flow through the lacrimal drainage system. Delivered using a prefilled injector with a cannula tip, the gel is inserted through the punctum and flows into the lacrimal sac. Extrusion of the gel through the upper punctum indicates that both the upper and lower canaliculi have been blocked. The device does not require customized sizing and can be removed through canalicular irrigation. In a comparative study, canalicular gel occlusion was evaluated against hydrogel punctal plugs, with follow-up at one, three, and six months. The gel was noninferior to the plugs at three months, and clinically and statistically significant improvements in dry-eye signs and symptoms were sustained through six months.3

Current Management and Emerging Treatments for Demodex Blepharitis

Treatment options include topical and oral antiparasitics, tea tree oil, and inoffice procedures such as intense pulsed light (IPL) and microblepharoexfoliation, although these procedures are not specific to Demodex. Lotilaner ophthalmic solution 0.25% represents a major advance in targeted treatment, although it is not currently available in Europe. In the SATURN-1 and SATURN-2 trials, six weeks of treatment significantly improved collarette clearance, mite eradication, and eyelid erythema compared with vehicle, with no serious drug-related adverse events reported.4 Emerging evidence suggests potential benefits for patients with concurrent Demodex blepharitis and MGD.5 By day 85, 63% of lotilaner-treated patients achieved an MGD severity grade of 2 or lower, compared with 24% in the vehicle group. Improvements in collarettes and dry eye symptoms, including burning and fluctuating vision, were also reported. Further research is needed to confirm these additional benefits.

REFERENCES 1. Ayres BD, Donnenfeld E, Farid M, et al. Clinical diagnosis and management of Demodex blepharitis: the Demodex Expert Panel on Treatment and Eyelid Health (DEPTH). Eye (Lond). 2023;37(15):3249-3255. 2. Yeu E, Wirta DL, Karpecki P, Baba SN, Holdbrook M. Lotilaner Ophthalmic Solution, 0.25%, for the Treatment of Demodex Blepharitis: Results of a Prospective, Randomized, Vehicle-Controlled, Double-Masked, Pivotal Trial (Saturn-1). Cornea. 2023;42(4):435-443. 3. Packer M, Lindstrom R, Thompson V, et al. Effectiveness and safety of a novel crosslinked hyaluronate canalicular gel occlusive device for dry eye. J Cataract Refract Surg. 2024;50(10):1051-1057. 4. Yeu E, Paauw JD, Vollmer P, et al. Safety and Efficacy of Lotilaner Ophthalmic Solution (0.25%) in Treating Demodex Blepharitis: Pooled Analysis of Two Pivotal Trials. Ophthalmol Ther. 2025;14(3). 5. Shen Lee B, Yeu E, Dhamdhere K, Donnenfeld ED. Impact of lotilaner ophthalmic solution 0.25% on disease severity in patients with Demodex blepharitis and meibomian gland disease. Front Med (Lausanne). 2026;13:1719825.

Prof. Béatrice Cochener-Lamard is Professor and Head of the Department of Ophthalmology at Brest University Hospital and Dean of the Faculty of Medicine and Health Sciences at the University of Western Brittany (UBO), Brest. She is past president of EuCornea and ESCRS. Prof. Cochener can be contacted at beatrice.cochener@ophtalmologie-chu29.fr.

Financial Disclosures: Clinical investigator and consultant for Thea, Johnson & Johnson, Bausch + Lomb, Hoya, ZEISS, Horus, Tarsus.

Conclusion

Effective preoperative ocular surface management relies on five key principles: screen every patient, identify and treat the underlying cause, postpone surgery until the ocular surface is stable, reassess after treatment, and educate patients about the potential impact of ocular surface disease on visual outcomes. Treatment should be tailored to the underlying condition and its severity, combining inflammation control, mechanical therapies, and lubrication as appropriate. Ultimately, optimizing the ocular surface before surgery improves measurement accuracy, enhances patient comfort and visual outcomes, and helps reduce postoperative dissatisfaction and the need for retreatment.

Modern Refractive Surgery–Bridging Technology, Outcomes, and Patient Expectations | EuroTimes Supplement November/December 2026

7


Meeting Patient Expectations in Myopia Correction BY CHRISTIAN AHLERS, PhD DR. MED.

Case Presentation

A 43-year-old patient with approximately -3.00 D of myopia in both eyes presented for refractive surgery. A slight degree of monovision was planned, targeting emmetropia in the right eye and -0.50 D in the left. The patient underwent Smooth Incision Lenticular Keratomileusis (SILK), a form of keratorefractive lenticule extraction (KLEx). A distinctive feature of the procedure is the ability to adjust centration after docking and compensate for cyclotorsion through manual marking. These adjustments allow the surgeon to refine lenticule alignment before treatment, potentially improving the accuracy of astigmatic correction and reducing the risk of residual astigmatism.

“The quality of lenticule dissection is an important consideration when assessing the surgical performance of the system.”

Technology Behind the Treatment

A key feature of SILK is its biconvex lenticule geometry. Combined with low-energy laser delivery, this design aims to support precise tissue removal while maintaining the cornea’s optical characteristics, including spherical aberration and depth of focus. Lenticule creation is designed to facilitate smooth dissection. The laser uses short pulses, a small focal spot, closely spaced laser spots, and low pulse energy to create a continuous cutting pattern (Table 1). Pulse energy must be carefully balanced to ensure reliable tissue separation. Excessively reducing the energy can make dissection of the posterior lenticule plane more challenging. Following lenticule creation, the surgeon separates the lenticule from the surrounding corneal tissue and extracts it through a small incision (Figure 1). Parameter

Specification

Repetition rate

10 MHz

Pulse duration

~150 fs (range: 100–250 fs)

Pulse energy

~38-90 nJ

Spot spacing

~1 µm

Laser/cut time

~15–16 s

Patient interface

Flat

Lenticule geometry

Biconvex

Scanning pattern

Radial, high-density

Centration

Adjustment after docking

Cyclotorsion compensation

Manual marking

Table 1. Technical specifications of the ELITA/SILK system.

Figure 1. Lenticule dissection and extraction. Courtesy of Dr. Christian Ahlers.

8

Precision, Recovery, and Patient Expectations

SILK is designed to provide predictable refractive correction across a range of myopic errors, supported by a treatment nomogram. Visual recovery can be rapid, with many patients achieving decimal visual acuity of 0.8-1.0 (approximately 20/25-20/20) on the first postoperative day. Recovery, however, varies among individuals. In the presented case, binocular uncorrected distance visual acuity (UDVA) was 0.0 logMAR on the first postoperative day and improved to −0.1 logMAR at weeks 1 and 12. At the 12-week assessment, the spherical equivalent was +0.25 D in the right eye and −0.25 D in the left. These results illustrate the visual and refractive outcomes achieved in this individual case. The system also allows control over lenticule geometry and thickness, supporting precise tissue removal and consistent lenticule creation.

Limitations and Patient Selection Despite these potential advantages, the technology has limitations, including the lack of current support for hyperopic correction. Potential challenges with cyclotorsion compensation and axis alignment may also arise in eyes with higher degrees of astigmatism. These considerations underscore the importance of appropriate patient selection and individualized treatment planning. As with any refractive procedure, suitability for SILK should

EuroTimes Supplement November/December 2026 | Modern Refractive Surgery–Bridging Technology, Outcomes, and Patient Expectations


be assessed in relation to the patient’s refractive error, corneal characteristics, visual needs, and expectations.

Conclusion

SILK combines a biconvex lenticule profile with closely spaced laser spots, short pulses, and low pulse energy to support precise lenticule creation and smooth dissection. Its flapless approach avoids flap-related complications, while potential benefits related to corneal nerve preservation and postoperative dry-eye risk warrant further evaluation. The ability to adjust centration after docking and compensate for cyclotorsion may support accurate astigmatic correction, although higher degrees of astigmatism can present additional challenges. These technical features offer potential advantages in refractive precision, but successful outcomes also depend on appropriate patient selection, individualized treatment planning, and surgical execution. Ultimately, meeting patient expectations depends on careful patient selection, accurate treatment planning, surgical precision, realistic counseling, and outcomes that align with each patient’s visual needs.

Dr. Christian Ahlers is an ophthalmic surgeon specializing in cataract and refractive. He is the founder and lead surgeon at Smarteye in northern Germany. Dr. Ahlers can be contacted at c.ahlers@ augenpartner.de.

Financial Disclosures: Johnson & Johnson MedTech Companies.

Lenticule Extraction for Myopic and Hyperopic Patients BY AADITHREYA VARMAN, MS, FAICO (CATARACT/PHACO), FWCRS

E

vidence supports the safety, efficacy, predictability, and long-term refractive stability of SMILE (Small Incision Lenticule Extraction) for correcting myopia and myopic astigmatism.1 The principles of lenticule extraction are also being applied to hyperopic correction, which requires different treatment geometry and precise centration. By removing a stromal lenticule rather than ablating the corneal surface, lenticule extraction may reduce corneal nerve disruption and the induction of spherical aberration, potentially helping preserve corneal asphericity.

Treatment Planning and Laser Optimization

Accurate preoperative refraction and careful treatment planning are essential for predictable outcomes. Because lenticule extraction may slightly undercorrect astigmatism, targeting the maximum acceptable cylinder correction is important. The optical zone should be approximately 0.5 mm larger than the scotopic pupil diameter, with a larger zone considered for higher refractive errors.

“Laser energy settings require a balance between safety and surgical efficiency.”

Energy settings must be optimized for effective lenticule creation and dissection. Insufficient energy can produce black spots and make dissection difficult, whereas excessive energy can cause an opaque bubble layer, complicate tissue separation, and delay visual recovery. Accurate centration and cyclotorsion control are also important. The VISUMAX 800 has a centration assistant that guides identification of the corneal vertex and helps position the treatment close to the visual axis. The system also supports automated cyclotorsion compensation. When preoperative iris images from biometry are available, they can be superimposed after docking to identify cyclotorsional changes and adjust treatment alignment.

Case Presentation 1: Myopic Astigmatism

In this patient with myopic astigmatism, the existing prescriptions were −4.50 D in the right eye and −5.00 D in the left eye, each with −1.50 D of cylinder. Manifest refraction revealed −3.00 D of cylinder, consistent with the 3.00 D difference between the steep and flat meridians on corneal topography. Topography was otherwise normal. The target refractions were −4.50 −3.00 D in the right eye and −5.25 −3.25 D in the left.

“A standardized, reproducible dissection technique is essential for achieving consistent results, beginning with optimal laser energy settings.” Dissection technique

With optimized energy settings, lenticule dissection can be performed with

Modern Refractive Surgery–Bridging Technology, Outcomes, and Patient Expectations | EuroTimes Supplement November/December 2026

9


Figure 1. Lenticule dissection. A gentle windshield-wiper motion separates the anterior interface without disturbing the incision, followed by controlled separation of the posterior interface. Broad sweeping motions are avoided to minimize the risk of lenticule damage. The side cuts are released last, allowing the intact lenticule to be freed and extracted. Courtesy of Dr. Aadithreya Varman.

minimal effort (Figure 1). The anterior (cap) interface is separated first, followed by the posterior interface.

Postoperative Outcomes

On the first postoperative day, best-corrected visual acuity (BCVA) was 6/6, N6 in the right eye and 6/5 (p), N6 in the left eye. Binocular visual acuity was 6/5 (p), N6. Autorefraction measured +0.50 DS/-0.75 DC x 130° in the right eye and +0.50 DS /-0.75 x 90° in the left eye. A published study involving 1,611 eyes with myopic astigmatism treated using the VISUMAX 800 reported that approximately 99% achieved 20/20 visual acuity, with no eyes losing two or more lines of BCVA.2 The spherical equivalent was within ±0.50 D of target in 98.7% of eyes and within ±1.00 D in 99.8%. With cyclotorsion adjustment, 97.3% of eyes achieved residual cylinder within ±0.50 D and 99.8% within ±1.00 D.

Case Presentation 2: Hyperopia

This hyperopic patient initially presented with +0.50 D and +1.00 D of cylinder. However, manifest refraction revealed +3.00 D of hyperopia and 1.50 D of astigmatism, indicating a substantially greater refractive error than initially anticipated. Hyperopic treatments require a different approach, making preoperative assessment particularly important. Although hyperopic SMILE follows the same basic principle as myopic SMILE, its treatment geometry differs. The larger lenticule accommodates a 2-mm transition zone, making precise centration particularly important. Decentration can result in an off-center island of tissue removal and induce significant spherical aberration, potentially compromising visual quality and patient satisfaction.

Dissection Technique and Postoperative Outcomes

Docking is performed as in myopic lenticule extraction. However, the lenticule is considerably larger in hyperopic treatment, with a reported total diameter of 8.3 mm, comprising a 6.3 mm optical zone and a 2 mm transition zone. The cap diameter is typically 8.8mm. The lenticule is particularly thin centrally, requiring careful dissection to avoid tearing. If the lenticule tears, it may need to be extracted in multiple pieces. In this hyperopic patient, autorefraction was +0.50 in both eyes, with BCVA of 6/6, N6 bilaterally on the first postoperative day.

The femtosecond laser approach offers potential biomechanical and optical advantages, including energy delivery across the treatment zone without the same fluence-projection effects associated with excimer laser ablation. These characteristics may help reduce induced spherical aberration. However, lenticule extraction does not currently offer the same customized wavefront- or topography-guided treatment options available with some excimer laser platforms. Ultimately, optimal visual outcomes depend on accurate preoperative assessment, appropriate treatment planning, optimized laser settings, precise centration, effective cyclotorsion compensation, and atraumatic tissue handling. REFERENCES: 1. Zhao, G.-H. et al. Ten-year evaluation on efficacy, safety, and predictability of femtosecond laser corneal small incision lenticule extraction for correction of myopia and myopic astigmatism: a case series. Annals of Medicine and Surgery 86, 6761 (2024). 2. Varman, A., Varman, N. V. A. & Adaikalam, K. Three-Month Visual and Refractive Outcomes of Keratorefractive Lenticule Extraction (KLEx) for Myopia and Myopic Astigmatism Using the VISUMAX 800 in 1611 Eyes. Ophthalmol. Ther. 15, 1705–1720 (2026).

Dr. Aadithreya Varman is a cataract and refractive surgeon who leads the phacoemulsification training program at Uma Eye Clinic, Chennai, India. He is an executive member of the Young Ophthalmologists Association in India. Dr. Varman can be contacted at aadithreyavarman@gmail.com.

Financial Disclosures: Consultant for Carl Zeiss Meditec.

Conclusion

Lenticule extraction is an established option for correcting myopia and astigmatism in appropriately selected patients. Hyperopic correction requires additional consideration of treatment geometry and centration.

10

EuroTimes Supplement November/December 2026 | Modern Refractive Surgery–Bridging Technology, Outcomes, and Patient Expectations


Maximizing Visual Quality for Moderate Myopes BY BARBARA LEYSSENS, MD

T

he EVO Implantable Collamer Lens (ICL) is a phakic intraocular lens designed to correct myopia and astigmatism. Its expanded 6.1 mm optic provides an optical zone of up to 7.6 mm at the corneal plane. This phakic IOL is made of biocompatible Collamer and has a central Aquaport, which facilitates aqueous humor circulation. The lens is implanted in the ciliary sulcus, with a generally accepted minimum anterior chamber depth (ACD) of 2.8 mm. With excellent laser vision correction (LVC) options available, it is important to understand where phakic IOLs fit in the treatment of moderate myopia. Surgeons may hesitate because implantation is intraocular surgery, raising concerns about potential complications, including vault-related issues and cataract formation. Practical considerations, such as preoperative measurements, lens-sizing calculations, diagnostic tools, and cost, may also influence their decisions. However, it may be time to look beyond traditional diopter thresholds and reconsider the role of phakic IOLs in moderate myopia. Both the published literature and our clinical experience at FYEO in the Netherlands support its place in comprehensive refractive surgery practice. In our series of 8,091 EVO ICL implantations, vault-related issues occurred in 0.85% of cases, compared with rates of approximately 1-1.5% reported in the literature. We recorded no cases of endophthalmitis, cataract, or pupillary block. These findings are consistent with the favorable safety profile described in the literature.1 Surgeons now have access to dedicated diagnostic devices, web-based calculators, and AI-assisted tools. The key is to establish a standardized workflow before incorporating additional tools.

“Start with a standardized workflow and build from there.”

Patient Selection: The Opting-In Approach

At FYEO, we advocate an opting-in approach: considering both phakic IOL and LVC from the outset, rather than relying on rigid diopter thresholds. The aim is to identify the most appropriate treatment for each patient based on age, future refractive needs, lifestyle, profession, and recovery expectations. It starts before the patient enters the clinic: websites and brochures should clearly present both options, helping patients make informed choices and supporting more personalized care. Both LVC and phakic IOLs can offer rapid visual recovery and excellent visual outcomes, and both can be performed bilaterally on the same day with topical anaesthesia. Both carry small surgical risks and may require enhancement procedures in 1% of cases. A phakic IOL may be particularly worth considering in selected patients with ocular surface concerns or when preserving corneal tissue is a priority. Its removability and potential flexibility for future refractive management are additional advantages, although visual phenomena requiring neuroadaptation and differences in cost should also be taken into account.

“Experience with both laser vision correction and phakic IOLs enables personalized treatment tailored to each patient’s eyes and future needs.”

Case Presentation

Our patient is a 25-year-old woman, a teacher, an active sports enthusiast, and a mother of two young children. Her corneal thickness is approximately 500 µm, with normal corneal topography. ACD measures 3.01 mm in the right eye and 3.13 mm in the left. Her refraction is −1.50 D sphere / −2.75 D cylinder in the right eye and −2.00 D sphere / −2.75 D cylinder in the left. She is seeking a procedure with a short recovery time. Contact lens wear has become increasingly difficult due to dry eye symptoms. Her active lifestyle and professional responsibilities are also important considerations, although she does not regularly drive long distances.

Treatment Decision

The estimated corneal ablation was approximately 64 µm across the laser treatment options considered. PRK was not selected because the prolonged recovery would be difficult to accommodate alongside her work and family responsibilities. LASIK was not selected given her existing dry eye symptoms and relatively thin corneas. Lenticule extraction also raises considerations regarding retreatment options in a young patient, an anticipated residual stromal thickness of approximately 300 µm, and the availability of technology for cyclotorsion control and accurate axis alignment. The suitability of corneal thickness thinner than 500 µm depends on individual clinical assessment and local practice standards. For this patient, a toric EVO ICL was selected based on her refractive error, ocular surface symptoms, corneal characteristics, and recovery expectations. It offers the potential for visual freedom and rapid visual recovery while preserving corneal tissue and minimizing additional impact on the ocular surface. It also allows flexibility for future refractive procedures, if needed, and precise toric alignment.

Modern Refractive Surgery–Bridging Technology, Outcomes, and Patient Expectations | EuroTimes Supplement November/December 2026 11


Figure 1. Toric EVO ICL implantation. Key steps showing positioning of the haptics beneath the iris and alignment of the lens to the intended axis.

Conclusion

Phakic IOLs, such as the EVO ICL, merit consideration alongside LVC in the treatment of moderate myopia, with treatment selection guided by individual ocular characteristics, lifestyle, and future refractive needs rather than rigid refractive thresholds. An opting-in approach can support personalized decision-making when surgeons critically evaluate the evidence and balance benefits and risks of each procedure.

Dr. Barbara Leyssens is an all-round refractive surgeon at FYEO clinics (part of EuroEyes) in the Netherlands and Medical Manager South Region Fyeo. Dr. Leyssens can be contacted at barbara@fyeo.nl.

REFERENCES 1. Packer, M. (2018). The Implantable Collamer Lens with a central port: review of the literature. Clinical Ophthalmology (Auckland, N.Z.), 12, 2427.

Financial Disclosures: Consultant for STAAR Surgical.

12

EuroTimes Supplement November/December 2026 | Modern Refractive Surgery–Bridging Technology, Outcomes, and Patient Expectations


Turn static files into dynamic content formats.

Create a flipbook
IME Supplement, November/December 2026, Modern Refractive Surgery by EUROTIMES - Issuu